CD44 and breast cancer: In this regard, studies of Zhou et al. demonstrated, that ZEB1 gain-of-function transfection in MDA-MB-231 breast cancer cells resulted in a higher tumorsphere formation capacity, a higher percentage of side-population cells, a higher fraction of CD44+CD24- breast CSC population and an increased ALDH activity [27].